Abstract 2792: The small molecule imipridone ONC201 is active in tumor types with dysregulation of the DRD2 pathway | Citedby Results | Cancer Research | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Abstract 2792: The small molecule imipridone ONC201 is active in tumor types with dysregulation of the DRD2 pathway

Cancer Res (2017) 77 (13_Supplement): 2792.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

ONC201 induces the unfolded protein response (UPR) in high‐ and low‐grade ovarian carcinoma cell lines and leads to cell death regardless of platinum sensitivity

Marufa Rumman
Steven Buck
Lisa Polin
Sijana Dzinic
Julie Boerner
Ira S. Winer

Cancer Medicine (2021) 10 (10): 3373.

Integrated stress response and immune cell infiltration in an ibrutinib‐refractory mantle cell lymphoma patient following ONC201 treatment

Jorge E. Romaguera
Hun J. Lee
Rohinton Tarapore
Varun Prabhu
Joshua Allen
Lee Schalop
Andrew Zloza
Chi Y. Ok
Evita T. Sadimin
Jason Schenkel
Maria Badillo
Michael Wang

British Journal of Haematology (2019) 185 (1): 133.

Role of Dopamine Receptors in the Anticancer Activity of ONC201

Christina Leah B. Kline
Marie D. Ralff
Amriti R. Lulla
Jessica M. Wagner
Phillip H. Abbosh
David T. Dicker
Joshua E. Allen
Wafik S. El-Deiry

Neoplasia (2018) 20 (1): 80.